Correction: MiR-451 as a new tumor marker for gastric cancer

Yong Shen^{1

2}, Jiao-Mei Gong³, Li-Li Zhou⁴, Jia-He Sheng²

Affiliations

¹ Department of Pathology and Pathophysiology, Medical School of Southeast University, Nanjing, Jiangsu, China.
² Department of Clinical Laboratory, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China.
³ Department of Clinical Laboratory, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
⁴ Department of Hepatobiliary Surgery, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Published Erratum

Yong Shen et al. Oncotarget. 2019.

. 2019 Oct 29;10(59):6396.

doi: 10.18632/oncotarget.27291.

Yong Shen^{1

2}, Jiao-Mei Gong³, Li-Li Zhou⁴, Jia-He Sheng²

¹ Department of Pathology and Pathophysiology, Medical School of Southeast University, Nanjing, Jiangsu, China.
² Department of Clinical Laboratory, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China.
³ Department of Clinical Laboratory, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
⁴ Department of Hepatobiliary Surgery, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.17239.].

MiR-451 as a new tumor marker for gastric cancer.
Shen Y, Gong JM, Zhou LL, Sheng JH. Shen Y, et al. Oncotarget. 2017 Apr 19;8(34):56542-56545. doi: 10.18632/oncotarget.17239. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915610 Free PMC article.